Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elias David-Neto

Showing results (111-120 of 112) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 112 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 20, 2021
Exploring the causes of the high incidence of delayed graft function after kidney transplantation in Brazil: a multicenter studyTainá Veras de Sandes-Freitas, Marilda Mazzali, Roberto Ceratti Manfro, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|January 22, 2025
Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individualsKarina Takesaki Miyaji, Karim Yaqub Ibrahim, Vanessa Infante, et al.
Pageof 12

Showing results (111-120 of 112) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 112 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 20, 2021
Exploring the causes of the high incidence of delayed graft function after kidney transplantation in Brazil: a multicenter studyTainá Veras de Sandes-Freitas, Marilda Mazzali, Roberto Ceratti Manfro, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|January 22, 2025
Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individualsKarina Takesaki Miyaji, Karim Yaqub Ibrahim, Vanessa Infante, et al.
Pageof 12